Tonix Pharmaceuticals Reports Positive Phase 3 Results for TNX-102 SL in Fibromyalgia, Submits NDA to FDA
Tonix Pharmaceuticals presented Phase 3 RESILIENT study results for TNX-102 SL, showing significant improvements in fibromyalgia symptoms. NDA submitted to FDA.Quiver AI SummaryTonix Pharmaceuticals presented...
Will Trump 2.0 Nurse Biotechs Back To Health: 10 Stocks Retail Is Watching
Less stringent requirements in pharmaceuticals and biotechnology could help biotechs by prompting accelerated drug approvals.